Skin care products
Galderma was founded in 1981 as a joint venture between L'Oreal and Nestle. Nestle took over full ownership in 2014, and then sold Galderma to a consortium of private institutional investors in 2019. Galderma is a global specialty pharmaceutical company dedicated exclusively to the field of dermatology. They operate manufacturing plants in France, Canada, Sweden and Brazil. Became a public company in March 2024.
Galderma SA
SWI
L'Oreal SA
owns 10% of Galderma SA
FRA
Cosmetics and beauty products maker
World's #1 beauty products company, and the top nanotechnology patent-holder in USA. Its ownership is split among several entities, including Nestle as a large stakeholder.
Company Assessment
(Last updated Jan 2023)
Praise
Criticism
Information
Galderma SA
Praise
Criticism
Information
The PalmOil Scan app, produced by the World Association of Zoos and Aquariums (WAZA), rates companies on their commitment to sourcing sustainable palm oil. Companies are scored on their use of certified sustainable palm oil (CSPO), commitment to sourcing CSPO, on-the-ground conservation action, and membership to the RSPO. Companies can earn a rating of Excellent, Good, Poor or No Commitment. This company is rated "No Commitment" (retrieved 18 Nov 2023).
Source: WAZA
(2023)
This company is a member of the Supplier Ethical Data Exchange (Sedex), a not-for-profit, membership organisation that leads work with buyers and suppliers to deliver improvements in responsible and ethical business practices in global supply chains. Tens of thousands of companies use Sedex to manage their performance around labour rights, health & safety, the environment and business ethics.
Source: Sedex
(2018)
Company Details
Type:
Public company
Employees:
5,000
Subsidiaries:
Galderma Australia Pty Ltd
Skin care products
Galderma is a global specialty pharmaceutical company dedicated exclusively to the field of dermatology. Created in 1981 as a joint venture between Nestle and L'Oreal, Nestle took over full ownership in 2014, and then sold Galderma to a consortium of private institutional investors in 2019.